RENEO PHARMACEUTICALS INC shareholders Q3 2023

RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 59 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 1.0%.

RENEO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 2,534,220$19,298,08547.73%
NEA Management Company, LLC 4,785,494$36,441,5372.81%
Aisling Capital Management LP 886,075$6,743,0312.78%
Octagon Capital Advisors LP 2,279,870$17,361,2102.67%
Novo Holdings A/S 3,330,377$25,344,1691.87%
GREAT POINT PARTNERS LLC 1,167,061$8,887,1701.62%
Carlyle Group Inc. 2,698,957$20,539,0630.89%
Eventide Asset Management 2,078,142$15,825,0510.28%
Rock Springs Capital Management LP 1,143,185$8,705,3540.23%
First Light Asset Management, LLC 272,317$2,073,6940.20%
J. Goldman & Co LP 155,410$1,183,4470.04%
Woodline Partners LP 450,646$3,431,6690.04%
ExodusPoint Capital Management, LP 378,977$2,8860.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 91,380$695,8590.02%
MAI Capital Management 123,720$942,1280.01%
Pale Fire Capital SE 14,851$113,0900.01%
Dorsey Wright & Associates 3,673$27,9700.01%
PRELUDE CAPITAL MANAGEMENT, LLC 14,800$112,7020.01%
FRANKLIN RESOURCES INC 1,493,356$11,371,9060.01%
Trexquant Investment LP 20,761$158,0950.00%
External links

This page lists RENEO PHARMACEUTICALS INC's shareholders in Q3 2023. To view RENEO PHARMACEUTICALS INC's shareholder history, click here.